Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trialMaxime Meylan, Kai W. Wucherpfennig, Daniel Kovarsky et al.|Cell|2026Cited by 10
Abstract 7743: Pre-existing T cells drive durable anti-tumor immunity after oncolytic virus therapy in glioblastomaMaxime Meylan, Kai W. Wucherpfennig, Ye Tian et al.|Cancer Research|2026Cited by 0